These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20135140)

  • 1. Reduced concentrations of angiogenesis-related factors in vitreous after vitrectomy in patients with proliferative diabetic retinopathy.
    Yoshida S; Ishikawa K; Matsumoto T; Yoshida A; Ishibashi T; Kono T
    Graefes Arch Clin Exp Ophthalmol; 2010 Jun; 248(6):799-804. PubMed ID: 20135140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic shift in vitreous after vitrectomy in patients with proliferative diabetic retinopathy.
    Yoshida S; Nakama T; Ishikawa K; Arima M; Tachibana T; Nakao S; Sassa Y; Yasuda M; Enaida H; Oshima Y; Kono T; Ishibashi T
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6997-7003. PubMed ID: 22977138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
    Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased vitreous concentrations of MCP-1 and IL-6 after vitrectomy in patients with proliferative diabetic retinopathy: possible association with postoperative macular oedema.
    Yoshida S; Kubo Y; Kobayashi Y; Zhou Y; Nakama T; Yamaguchi M; Tachibana T; Ishikawa K; Arita R; Nakao S; Sassa Y; Oshima Y; Kono T; Ishibashi T
    Br J Ophthalmol; 2015 Jul; 99(7):960-6. PubMed ID: 25631486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreous hepatocyte growth factor in patients with proliferative diabetic retinopathy: a case-control study.
    Simó R; Vidal MT; García-Arumí J; Carrasco E; García-Ramírez M; Segura RM; Hernández C
    Diabetes Res Clin Pract; 2006 Jan; 71(1):36-44. PubMed ID: 16029908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraocular tumour necrosis factor ligand related molecule 1 A links disease progression of proliferative diabetic retinopathy after primary vitrectomy.
    Wang T; Li J; Xie R; Wang J; Zhang W; Jiang F; Du M; Wang X; Huang B; Brant R; Zhang C; Yan H
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):966-976. PubMed ID: 32064668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
    Itakura H; Kishi S; Kotajima N; Murakami M
    Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
    Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
    Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ang-2 upregulation correlates with increased levels of MMP-9, VEGF, EPO and TGFβ1 in diabetic eyes undergoing vitrectomy.
    Loukovaara S; Robciuc A; Holopainen JM; Lehti K; Pessi T; Liinamaa J; Kukkonen KT; Jauhiainen M; Koli K; Keski-Oja J; Immonen I
    Acta Ophthalmol; 2013 Sep; 91(6):531-9. PubMed ID: 23106921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kinetics of VEGF and MCP-1 in the second vitrectomy cases with proliferative diabetic retinopathy.
    Sassa Y; Yoshida S; Ishikawa K; Asato R; Ishibashi T; Kono T
    Eye (Lond); 2016 May; 30(5):746-53. PubMed ID: 26915745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.
    Abu El-Asrar AM; Nawaz MI; De Hertogh G; Al-Kharashi AS; Van den Eynde K; Mohammad G; Geboes K
    Curr Eye Res; 2015 Mar; 40(3):321-31. PubMed ID: 24871583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of alphaB-crystallin in vitreous fluid of patients with proliferative diabetic retinopathy and correlation with vascular endothelial growth factor.
    Chen W; Lu Q; Lu L; Guan H
    Clin Exp Ophthalmol; 2017 May; 45(4):379-384. PubMed ID: 27928876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble IL-6 receptor in vitreous fluid of patients with proliferative diabetic retinopathy.
    Kawashima M; Shoji J; Nakajima M; Kamura Y; Sato Y
    Jpn J Ophthalmol; 2007; 51(2):100-4. PubMed ID: 17401618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy.
    Ogata N; Nishikawa M; Nishimura T; Mitsuma Y; Matsumura M
    Am J Ophthalmol; 2002 Sep; 134(3):348-53. PubMed ID: 12208245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vitreous levels of stromal cell-derived factor-1 and vascular endothelial growth factor in diabetic retinopathy].
    Chen L; Lü L; Li Y; Huang X; Zhang J; Li S
    Yan Ke Xue Bao; 2008 Mar; 24(1):6-8. PubMed ID: 18709948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Profile of Angiogenic Factors in Vitreous Humor of the Patients with Proliferative Diabetic Retinopathy.
    Yu Y; Zhang J; Zhu R; Zhao R; Chen J; Jin J; Tian Y; Su SB
    Curr Mol Med; 2017 Dec; 17(4):280-286. PubMed ID: 29110608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders.
    Katsura Y; Okano T; Noritake M; Kosano H; Nishigori H; Kado S; Matsuoka T
    Diabetes Care; 1998 Oct; 21(10):1759-63. PubMed ID: 9773744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of ranibizumab on the level of intercellular adhesion molecule type 1 in the vitreous of eyes with proliferative diabetic retinopathy.
    Yan Y; Zhu L; Hong L; Deng J; Song Y; Chen X
    Acta Ophthalmol; 2016 Jun; 94(4):358-64. PubMed ID: 26285163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitreous and plasma concentrations of apelin and vascular endothelial growth factor after intravitreal bevacizumab in eyes with proliferative diabetic retinopathy.
    Qian J; Lu Q; Tao Y; Jiang YR
    Retina; 2011 Jan; 31(1):161-8. PubMed ID: 20890241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.